Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Colorcon
Accenture
McKinsey
McKesson
Johnson and Johnson

Generated: May 24, 2019

DrugPatentWatch Database Preview

Actavis Labs Ut Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS UT INC, and what generic and branded alternatives to ACTAVIS LABS UT INC drugs are available?

ACTAVIS LABS UT INC has nineteen approved drugs.

There is one tentative approval on ACTAVIS LABS UT INC drugs.

Summary for Actavis Labs Ut Inc
US Patents:0
Tradenames:20
Ingredients:15
NDAs:19

Drugs and US Patents for Actavis Labs Ut Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc LIDOCAINE lidocaine PATCH;TOPICAL 200675-001 Aug 23, 2012 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc FLUOCINOLONE ACETONIDE fluocinolone acetonide SOLUTION;TOPICAL 208386-001 Oct 21, 2016 AT RX No No ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc FENTANYL-100 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 076709-004 Aug 20, 2007 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc CLONIDINE clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 090873-002 May 6, 2014 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc FENTANYL-75 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 076709-003 Aug 20, 2007 DISCN No No ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc AZELAIC ACID azelaic acid GEL;TOPICAL 208011-001 Nov 19, 2018 AB RX No No ➤ Sign Up ➤ Sign Up
Actavis Labs Ut Inc TESTOSTERONE testosterone GEL;TRANSDERMAL 076737-002 Jan 27, 2006 AB1 RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for Actavis Labs Ut Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut Inc LOXITANE IM loxapine hydrochloride INJECTABLE;INJECTION 018039-001 Approved Prior to Jan 1, 1982 3,546,226 ➤ Sign Up
Actavis Labs Ut Inc EMLA lidocaine; prilocaine CREAM;TOPICAL 019941-001 Dec 30, 1992 4,529,601 ➤ Sign Up
Actavis Labs Ut Inc EMLA lidocaine; prilocaine CREAM;TOPICAL 019941-001 Dec 30, 1992 4,562,060 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Queensland Health
McKesson
US Department of Justice
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.